Watchlist Price Alert

Aptose Biosciences Inc. (APTO)

NASDAQ: APTO · Real-Time Price · USD

1.71

0.00 (0.00%)

At close: Apr 01, 2025, 3:59 PM

Aptose Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-25.43M	-51.21M	-41.82M	-65.35M	-55.24M	-26.28M	-28.87M	-11.64M	-14.24M
Depreciation & Amortization	404K	466K	528K	622K	614K	613K	87K	84K	114.83K
Stock-Based Compensation	1.06M	3.65M	5.21M	12.95M	21.44M	2.3M	4.28M	817K	1.71M
Other Working Capital	-6.24M	2.45M	-126.67K	1.99M	-486.84K	1.24M	-53K	544K	-126K
Other Non-Cash Items	-986K	48.9K	-551K	6.96M	-429.16K	-78K	625K	-25K	244.38K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-11.03M	2.45M	4.32M	1.52M	-275.84K	1.89M	673K	544K	n/a
Operating Cash Flow	-35.98M	-44.59M	-32.32M	-43.3M	-33.89M	-21.56M	-23.21M	-10.22M	-12.17M
Capital Expenditures	-5K	-29K	-24K	-212K	-79K	-102K	-329K	-13K	-3.73K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-35M	n/a	-17.27M	n/a	-798K	n/a
Sales Maturities Of Investments	n/a	9.99M	28.9M	n/a	12.71M	n/a	341K	n/a	6.4M
Other Investing Acitivies	23K	n/a	1.19M	n/a	n/a	n/a	n/a	n/a	-192.38K
Investing Cash Flow	18K	9.96M	30.07M	-35.21M	12.63M	-17.37M	12K	-811K	6.21M
Debt Repayment	10M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	26K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	28K	29K	15K	190K	405K	10.28M	2.15M	13.22M	n/a
Financial Cash Flow	33.41M	6.91M	116K	226K	58.81M	103.45M	27.87M	13.72M	5.73M
Net Cash Flow	-2.54M	-27.72M	-2.14M	-78.28M	37.55M	64.54M	4.67M	2.69M	-371K
Free Cash Flow	-35.98M	-44.62M	-32.35M	-43.52M	-33.97M	-21.66M	-23.54M	-10.24M	-12.39M